Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.

Antimicrobial agents and chemotherapy - 1 Jan 1999

Mouneimné H, Robert J, Jarlier V, Cambau E

Abstract excerpt

We determined the sequences of the quinolone resistance-determining regions of gyrA, gyrB, and parC genes for 30 clinical strains of Pseudomonas aeruginosa resistant to ciprofloxacin that were previously complemented by wild-type gyrA and gyrB plasmid-borne alleles and studied for their coresistance to imipenem (E. Cambau, E. Perani, C. Dib, C. Petinon, J. Trias, and V. Jarlier, Antimicrob. Agents Chemother....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Base Sequence
Share to DNA Topoisomerases, Type II

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Microbial Sensitivity Tests

Share to Molecular Sequence Data

Share to Mutation

Share to Pseudomonas aeruginosa

Source

Open in PubMed Open full text

Identifiers

PMID: 9869566
DOI: 10.1128/AAC.43.1.62
PMCID: PMC89021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa.PMID 9869566Read ↗

The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.Semantic proximity Read ↗

Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.Semantic proximity Read ↗

Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.Semantic proximity Read ↗

Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumanniiSemantic proximity Read ↗

Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.Semantic proximity Read ↗

The role of Gene Mutations (gyrA, parC) in Resistance to Ciprofloxacin in Clinical Isolates of Pseudomonas AeruginosaSemantic proximity Read ↗

Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in VietnamSemantic proximity Read ↗

Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.Semantic proximity Read ↗

Mutations in DNA Gyrase and Topoisomerase IV in Ciprofloxacin-Nonsusceptible Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.Semantic proximity Read ↗

Alterations in the GyrA Subunit of DNA Gyrase and the ParC Subunit of DNA Topoisomerase IV Associated with Quinolone Resistance in Enterococcus faecalisSemantic proximity Read ↗

Mutations in the quinolone resistance-determining regions of gyrA and parC in Enterobacteriaceae isolates from BrazilSemantic proximity Read ↗

Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniaeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.